Publications:429
Mary Sano, PhD
Psychology
No Patient Experience Ratings
About Me
Dr. Mary Sano is Professor of Psychiatry and the Director of the Alzheimer's Disease Research at Mount Sinai School of Medicine. She is also the Director of Research and Development at the Bronx Veterans Administration Hospital. Currently she is the director of a national multi-center study known as CLASP (Cholesterol Lowering in Alzheimer's Disease to Slow Progression). Dr. Sano is a neuropsychologist by training and has been involved in designing and conducting clinical trials for Alzheimer's disease, Parkinson's disease, and mild cognitive impairment of aging. In 1989 she received the Florence and Herbert Irving Clinical Research Career Award to develop methodologies for the assessment of therapeutic agents in Alzheimer's disease. She directed the first ADCS multicenter trial of vitamin E and Selegiline, treatments which delayed the clinical progression of Alzheimer's disease and in 1998 she received the Veris Award for this study. In this study minority participation was more than double that of any other clinical trial for this disease. Her research interests are in clinical trial design and the impact of pharmacological treatments on the functional abilities of individuals with cognitive impairment.
At present she is the director of a new clinical study to determine if home based assessments can be used assess treatments for the prevention of cognitive loss and dementia. She has also developed tools to assess the economic impact of subtle cognitive changes in elderly subjects. Other areas of interest include the role of depression in cognitive impairment and dementia, womens' attitudes about prevention of memory loss, and measuring quality of life in diseases of aging. She is also the recipient of the Alzheimer Association grant to study Resveritrol, one of the active ingredients in red wine. Dr. Sano has also conducted work characterizing the cognitive impact of head injury, Sickle Cell disease, and mitochondrial disorders.
{C}
In the News
{C}
Dr. Sano shares tips to help reduce the risk and ease the symptoms of Alzheimer's in The Daily News feature The Daily Check Up. View the PDF.
Language
English
Position
ASSOCIATE DEAN FOR CLINICAL RESEARCH, PROFESSOR | Psychiatry
Hospital Affiliations
- The Mount Sinai Hospital
Clinical Focus
- Alzheimer's Disease
Education
Internship, Clinical Neuropsychology
Columbia University Irving Medical Center
Insurance Information
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s disease. Jeffrey L. Cummings, Alireza Atri, Howard H. Feldman, Oskar Hansson, Mary Sano, Filip K. Knop, Peter Johannsen, Teresa León, Philip Scheltens. Alzheimer's Research and Therapy
- Prognostic value of plasma biomarkers for informing clinical trial design in mild-to-moderate Alzheimer’s disease. Yuqi Qiu, Diane M. Jacobs, Karen Messer, David P. Salmon, Cheryl L. Wellington, Sophie Stukas, Carolyn Revta, James B. Brewer, Gabriel C. Léger, Brianna Askew, Lia Donahue, Stephen Kaplita, Vladimir Coric, Irfan A. Qureshi, Howard H. Feldman, Mark Brody, Jeffrey Ross, Anna Burke, Sudha Seshadri, Cherian Verghese, Stephen Flitman, Peter McCallister, Richard Shubin, Alexander Beyzer, James J. Peters, Mary Sano, Maya Lichtenstein, Clifford Singer, David Weisman, Kiran Bath, Olga Tchikindas, Sharon Brangman, Christos Sidiropoulos, Andrea Bozoki, Jeffrey Keller, Bernard Baumel, Olga Brawman-Mintzer, Jacobo Mintzer, Michael Karathanos, Ralph Richter, Charles Bernick, Aaron Ritter, Jonathan Drake, Elaine Peskind, Del D. Miller, Douglas Scharre, Alan Lerner, Alireza Atri, Bryan Spann, Alan Siegal. Alzheimer's Research and Therapy
- Ethnicity predicts long-term depressive symptom patterns in older adults with type 2 diabetes. Yuxia Ouyang, David Manier, Ramit Ravona-Springer, Mery Mamistalov, Dar Gelblum, Anthony Heymann, Joseph Azuri, Laili Soleimani, Ruby Phillips, Mary Sano, Michal Schnaider Beeri, Elizabeth Guerrero-Berroa. International Psychogeriatrics
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Sano has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.